These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20629473)

  • 1. The value of value of information: best informing research design and prioritization using current methods.
    Eckermann S; Karnon J; Willan AR
    Pharmacoeconomics; 2010; 28(9):699-709. PubMed ID: 20629473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of value of information in UK health technology assessments.
    Mohiuddin S; Fenwick E; Payne K
    Int J Technol Assess Health Care; 2014 Dec; 30(6):553-70. PubMed ID: 25816821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Decision Makers' Constraints on the Outcome of Value of Information Analysis.
    Koffijberg H; Knies S; Janssen MP
    Value Health; 2018 Feb; 21(2):203-209. PubMed ID: 29477402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.
    Rothery C; Strong M; Koffijberg HE; Basu A; Ghabri S; Knies S; Murray JF; Sanders Schmidler GD; Steuten L; Fenwick E
    Value Health; 2020 Mar; 23(3):277-286. PubMed ID: 32197720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.
    Claxton K; Ginnelly L; Sculpher M; Philips Z; Palmer S
    Health Technol Assess; 2004 Jul; 8(31):1-103, iii. PubMed ID: 15248937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
    Siebert U; Rochau U; Claxton K
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events.
    Basu A; Meltzer D
    Med Decis Making; 2018 May; 38(4):427-438. PubMed ID: 29529923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication.
    Groot Koerkamp B; Spronk S; Stijnen T; Hunink MG
    Value Health; 2010; 13(2):242-50. PubMed ID: 19818058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis.
    Tappenden P; Chilcott JB; Eggington S; Oakley J; McCabe C
    Health Technol Assess; 2004 Jun; 8(27):iii, 1-78. PubMed ID: 15215017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment.
    Kim DD; Guzauskas GF; Bennette CS; Basu A; Veenstra DL; Ramsey SD; Carlson JJ
    Pharmacoeconomics; 2020 Feb; 38(2):171-179. PubMed ID: 31631254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjusting Estimates of the Expected Value of Information for Implementation: Theoretical Framework and Practical Application.
    Andronis L; Barton PM
    Med Decis Making; 2016 Apr; 36(3):296-307. PubMed ID: 26566775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presenting evidence and summary measures to best inform societal decisions when comparing multiple strategies.
    Eckermann S; Willan AR
    Pharmacoeconomics; 2011 Jul; 29(7):563-77. PubMed ID: 21671686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of Information for Clinical Trial Design: The Importance of Considering All Relevant Comparators.
    Heath A; Baio G; Manolopoulou I; Welton NJ
    Pharmacoeconomics; 2024 May; 42(5):479-486. PubMed ID: 38583100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expected value of information and decision making in HTA.
    Eckermann S; Willan AR
    Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer.
    Hoomans T; Fenwick EA; Palmer S; Claxton K
    Value Health; 2009; 12(2):315-24. PubMed ID: 18657098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Globally optimal trial design for local decision making.
    Eckermann S; Willan AR
    Health Econ; 2009 Feb; 18(2):203-16. PubMed ID: 18435429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation Barriers to Value of Information Analysis in Health Technology Decision Making: Results From a Process Evaluation.
    Grimm SE; Pouwels X; Ramaekers BLT; van Ravesteyn NT; Sankatsing VDV; Grutters J; Joore MA
    Value Health; 2021 Aug; 24(8):1126-1136. PubMed ID: 34372978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Practical Application of Value of Information and Prospective Payback of Research to Prioritize Evaluative Research.
    Andronis L; Billingham LJ; Bryan S; James ND; Barton PM
    Med Decis Making; 2016 Apr; 36(3):321-34. PubMed ID: 26209474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.